We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA CONTROVERSIES MAY DRAW CONGRESSIONAL OVERSIGHT
FDA CONTROVERSIES MAY DRAW CONGRESSIONAL OVERSIGHT
November 16, 2004
Controversies surrounding the FDA's role in the handling of several recent high-profile cases could lead to greater congressional oversight of the agency, according to some Washington observers.